Autologous Lymphokine-Activated Killer Cell Therapy of Lymphoproliferative Disorders Arising in Organ Transplant Recipients

By Nalesnik M.A.   Rao A.S.   Zeevi A.   Fung J.J.   Pham S.   Furukawa H.   Gritsch A.   Klein G.   Starzl T.E.  

Transplantation Proceedings, Vol. 29, Iss. 3, 1997-05 ,pp. : 1905-1906

Elsevier

Access to resources Recommend Favorite

Human Immunodeficiency Virus (HIV) Type-1 GP120-Specific Cell-Mediated Cytotoxicity (CMC) and Natural Killer (NK) Activity in HIV-Infected (HIV + ) Subjects: Enhancement with Interleukin-2(IL-2), IL-12, and IL-15

By Lin S.J.   Roberts R.L.   Ank B.J.   Nguyen Q.H.   Thomas E.K.   Stiehm E.R.  

Clinical Immunology, Vol. 82, Iss. 2, 1997-02 ,pp. : 163-173

Academic Press

Access to resources Recommend Favorite

Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes

By Gao Ning   Jennings Paula   Yuan Dorothy  

International Immunology, Vol. 20, Iss. 5, 2008-05 ,pp. : 645-657

Oxford University Press

Access to resources Recommend Favorite

Endogenous IL-33 enhances T h 2 cytokine production and T-cell responses during allergic airway inflammation

By Louten Jennifer   Rankin Andrew L.   Li Ying   Murphy Erin E.   Beaumont Maribel   Moon Christina   Bourne Patricia   McClanahan Terrill K.   Pflanz Stefan   de Waal Malefyt Rene  

International Immunology, Vol. 23, Iss. 5, 2011-05 ,pp. : 307-315

Oxford University Press

Access to resources Recommend Favorite

FasL expression on pig cells suppresses human natural killer cell mediated-cytotoxicity

By Nakajima H.   Fujiwara I.   Matsuda T.   Mizuta N.   Yamagishi H.   Oka T.   Yoshimura N.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2704-2706

Elsevier

Access to resources Recommend Favorite